stattic Search Results


99
MedChemExpress stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/Stattic/pmc12189954-176-5-17
Average 99 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

95
TargetMol hy 12468
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Hy 12468, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/Stattic/pmc13558900-372-0-6
Average 95 stars, based on 1 article reviews
hy 12468 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Tocris stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/Stattic/pmc05707056-156-0-4
Average 93 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology stat3 inhibitor v stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stat3 Inhibitor V Stattic, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/Stat3+inhibitor+V%2C+stattic/pmc04859653-116-0-12
Average 93 stars, based on 1 article reviews
stat3 inhibitor v stattic - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Selleck Chemicals stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/Stattic/pm35088742-110-5-12
Average 96 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/Stattic/pmc05053649-148-27-28
Average 93 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Merck KGaA stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/stattic/pm36054818-45-25-26
Average 90 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GlpBio Technology Inc stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/stattic/pmc10997778-434-36-41
Average 90 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ApexBio stattic
To verify the effect of YOD1 on STAT3, the STAT3 inhibitor <t>Stattic</t> (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected <t>with</t> <t>Ang</t> II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.
Stattic, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/stattic/pmc04990205-75-2-9
Average 90 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co stattic
A. Cells (2 × 10 3 ) were plated into 96-well plates and 6 hours later medium was changed to either NG (5.5 mmol/L D-glucose), Mtol (25 mmol/L D-mannitol), HG (25 mmol/L D-Glucose), HG+Quer (25 mmol/L D-Glucose + 5.5 <t>μmmol/L</t> <t>quercetagetin),</t> <t>HG+Stattic</t> (25 mmol/L D-Glucose + 10 μmol/L stattic), or HG+DMSO (25 mmol/L D-Glucose + 0.3% (v/v) DMSO) for 48 hours and the CCK-8 assay was used to detect cell viability. ** P < 0.01 vs . NG or Mtol, # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. B. Cells (5×10 5 ) were plated into 6-well plates and 6 hours later the medium was changed as described above for an additional 48 hours and cell numbers were counted. * P < 0.05 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO. C. qRT-PCR and D. western blotting were used to examine the expression of PCNA. ** P < 0.01 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. Quer, quercetagetin.
Stattic, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/stat3/pmc05687607-133-18-23
Average 90 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CEM Corporation stattic
A. Cells (2 × 10 3 ) were plated into 96-well plates and 6 hours later medium was changed to either NG (5.5 mmol/L D-glucose), Mtol (25 mmol/L D-mannitol), HG (25 mmol/L D-Glucose), HG+Quer (25 mmol/L D-Glucose + 5.5 <t>μmmol/L</t> <t>quercetagetin),</t> <t>HG+Stattic</t> (25 mmol/L D-Glucose + 10 μmol/L stattic), or HG+DMSO (25 mmol/L D-Glucose + 0.3% (v/v) DMSO) for 48 hours and the CCK-8 assay was used to detect cell viability. ** P < 0.01 vs . NG or Mtol, # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. B. Cells (5×10 5 ) were plated into 6-well plates and 6 hours later the medium was changed as described above for an additional 48 hours and cell numbers were counted. * P < 0.05 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO. C. qRT-PCR and D. western blotting were used to examine the expression of PCNA. ** P < 0.01 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. Quer, quercetagetin.
Stattic, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stattic/stattic/pmc11653168-111-3-1
Average 90 stars, based on 1 article reviews
stattic - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


To verify the effect of YOD1 on STAT3, the STAT3 inhibitor Stattic (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected with Ang II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.

Journal: Science Advances

Article Title: Cardiomyocyte-derived YOD1 promotes pathological cardiac hypertrophy by deubiquitinating and stabilizing STAT3

doi: 10.1126/sciadv.adu8422

Figure Lengend Snippet: To verify the effect of YOD1 on STAT3, the STAT3 inhibitor Stattic (10 mg/kg, gavage) or vehicle [0.5% O -carboxymethylcellulose (CMC)–Na and 0.25% Tween 80] was administered every 3 days via oral gavage. Healthy male YOD1CKO mice aged 6 to 8 weeks and YOD1 fl/fl mice were injected with Ang II (1 μg kg –1 min –1 ) or normal saline via an osmotic pump (catalog no. ALZET Model 1004, USA) for 4 weeks to induce cardiac hypertrophy. ( A ) Representative M-mode echocardiography of mice in each group. ( B and C ) Myocardial function parameters, including EF (B) and FS (C), were evaluated in mice through echocardiography. ( D ) The plasma levels of ANP in each group. ( E ) Representative images of whole hearts. Scale bars, 2.5 mm. ( F ) Representative images of H&E staining of transverse section in myocardium tissues. Scale bars, 2.5 mm and 50 μm. ( G and H ) Representative images of WGA (G) staining in sections of hearts and quantitative area analysis (H). Scale bars, 50 μm. ( I to L ) Fibrotic areas were evaluated using Masson’s trichrome (I) and Sirius Red (K) staining, as well as the quantification of fibrotic regions (H and J) in heart sections from each group. Scale bars, 50 μm. ( M and N ) Representative Western blot analysis of MyHC and ANP (M) and densitometric quantification (N). n = 6. n.s., P > 0.05; *** P < 0.001.

Article Snippet: Ang II (catalog no. HY-13948), Stattic (catalog no. HY-13818), and CHX (catalog no. HY-12320) were obtained from MedChemExpress (New Jersey, USA).

Techniques: Injection, Saline, Clinical Proteomics, Staining, Western Blot

A. Cells (2 × 10 3 ) were plated into 96-well plates and 6 hours later medium was changed to either NG (5.5 mmol/L D-glucose), Mtol (25 mmol/L D-mannitol), HG (25 mmol/L D-Glucose), HG+Quer (25 mmol/L D-Glucose + 5.5 μmmol/L quercetagetin), HG+Stattic (25 mmol/L D-Glucose + 10 μmol/L stattic), or HG+DMSO (25 mmol/L D-Glucose + 0.3% (v/v) DMSO) for 48 hours and the CCK-8 assay was used to detect cell viability. ** P < 0.01 vs . NG or Mtol, # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. B. Cells (5×10 5 ) were plated into 6-well plates and 6 hours later the medium was changed as described above for an additional 48 hours and cell numbers were counted. * P < 0.05 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO. C. qRT-PCR and D. western blotting were used to examine the expression of PCNA. ** P < 0.01 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. Quer, quercetagetin.

Journal: Oncotarget

Article Title: High glucose promotes vascular smooth muscle cell proliferation by upregulating proto-oncogene serine/threonine-protein kinase Pim-1 expression

doi: 10.18632/oncotarget.19368

Figure Lengend Snippet: A. Cells (2 × 10 3 ) were plated into 96-well plates and 6 hours later medium was changed to either NG (5.5 mmol/L D-glucose), Mtol (25 mmol/L D-mannitol), HG (25 mmol/L D-Glucose), HG+Quer (25 mmol/L D-Glucose + 5.5 μmmol/L quercetagetin), HG+Stattic (25 mmol/L D-Glucose + 10 μmol/L stattic), or HG+DMSO (25 mmol/L D-Glucose + 0.3% (v/v) DMSO) for 48 hours and the CCK-8 assay was used to detect cell viability. ** P < 0.01 vs . NG or Mtol, # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. B. Cells (5×10 5 ) were plated into 6-well plates and 6 hours later the medium was changed as described above for an additional 48 hours and cell numbers were counted. * P < 0.05 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO. C. qRT-PCR and D. western blotting were used to examine the expression of PCNA. ** P < 0.01 vs . NG or Mtol; # P < 0.05 vs . HG or HG+DMSO, ## P < 0.01 vs . HG or HG+DMSO. Quer, quercetagetin.

Article Snippet: Cells were cultured in NG, Mtol and HG media supplemented with quercetagetin (5.5 μmol/L, Pim-1 inhibitor, Merck, Germany), stattic (10 μmol/L, STAT3 inhibitor, Merck) and dimethylsulphoxide (DMSO, ≤0.3%, v/v) for 48 hours.

Techniques: CCK-8 Assay, Quantitative RT-PCR, Western Blot, Expressing

A. p-STAT3(Y705) and STAT3 expression in VSMCs were detected by western blotting. B. Ratio of p-STAT3(Y705)/STAT3. *** P < 0.001 vs. NG, Mtol, or HG+Stattic. C. qRT-PCR and D. western blotting were used to examine Pim-1 mRNA and protein expression in HG-treated VSMCs, respectively. *** P < 0.001 vs. HG or HG+DMSO.

Journal: Oncotarget

Article Title: High glucose promotes vascular smooth muscle cell proliferation by upregulating proto-oncogene serine/threonine-protein kinase Pim-1 expression

doi: 10.18632/oncotarget.19368

Figure Lengend Snippet: A. p-STAT3(Y705) and STAT3 expression in VSMCs were detected by western blotting. B. Ratio of p-STAT3(Y705)/STAT3. *** P < 0.001 vs. NG, Mtol, or HG+Stattic. C. qRT-PCR and D. western blotting were used to examine Pim-1 mRNA and protein expression in HG-treated VSMCs, respectively. *** P < 0.001 vs. HG or HG+DMSO.

Article Snippet: Cells were cultured in NG, Mtol and HG media supplemented with quercetagetin (5.5 μmol/L, Pim-1 inhibitor, Merck, Germany), stattic (10 μmol/L, STAT3 inhibitor, Merck) and dimethylsulphoxide (DMSO, ≤0.3%, v/v) for 48 hours.

Techniques: Expressing, Western Blot, Quantitative RT-PCR